Vervloet, Marc G.
Amsterdam University Medical Centers · Amsterdam Cardiovascular Sciences
3 papers on CoChatORCID 0000-0003-4607-9415
Most cited papers
- Verified
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
Cherney, D. Z. I., Dekkers, C. C. J., Barbour, S. J., Cattran, D., Abdul Gafor, A. H., Greasley, P. J., Laverman, G. D., Lim, S. K., Di Tanna, G. L., Reich, H. N., et al. (2020) · The Lancet Diabetes & Endocrinology
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 283
- Verified
Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease
de Borst, M. H., Vervloet, M. G., ter Wee, P. M., & Navis, G. (2011) · Journal of the American Society of Nephrology
Parathyroid Disorders and TreatmentsChronic Kidney Disease and Diabetes
Cited by 282
- Verified
Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23
Vervloet, M. G., van Ittersum, F. J., Büttler, R. M., Heijboer, A. C., Blankenstein, M. A., & ter Wee, P. M. (2011) · Clinical Journal of the American Society of Nephrology
Parathyroid Disorders and TreatmentsVitamin D Research Studies
Cited by 218
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free